Peter D. O'Hanley
Corporate Officer/Principal bij Stanford University
Profiel
Peter D.
O'Hanley was Senior Vice President of Clinical Development and Regulatory Affairs for AVI BioPharma, Inc. from March 2004 to January 9, 2009.
From 2002 to 2003, he was Vice President of Clinical Development for Maxygen, Inc. and Chief Scientific Officer of Preventis, Inc. from 2000 to 2003.
Dr. O'Hanley was Vice President and Chief Scientific Officer of the Anti-Infective Therapeutic & Immunology Therapeutic Groups for Quintiles, Inc. from 1998 to 2000.
He was a Visiting Clinical Scientist of Shaman Pharmaceuticals from 1996 to 1997 and an Associate Professor at the Stanford University School of Medicine from 1985 to 1998.
Dr. O'Hanley received a BA degree in Zoology from Pomona College, a PhD in Anatomy and an MD from the Medical University of South Carolina and an MPH in Epidemiology from the University of California at Berkeley.
Actieve functies van Peter D. O'Hanley
| Bedrijven | Functie | Begin |
|---|---|---|
| Stanford University | Corporate Officer/Principal | 01-01-1985 |
Eerdere bekende functies van Peter D. O'Hanley
| Bedrijven | Functie | Einde |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 09-01-2009 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Chief Tech/Sci/R&D Officer | 01-01-2003 |
| Preventis, Inc. | Chief Tech/Sci/R&D Officer | 01-01-2003 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01-01-2000 |
Opleiding van Peter D. O'Hanley
| Pomona College | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
| University of California, Berkeley | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
| Preventis, Inc. |
